Weight loss medication Unlike other programs, Levity includes the full cost of your medication
JMIR Cancer
16 Ludvik, B., et al., Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Step 3: Ongoing Follow-Ups and Adjustments Follow-up visits allow us to: Monitor your response, including changes in appetite, energy, and weight Review lab results as needed Adjust dosage or timing to support steady progress Address any side effects early This supervised weight program keeps you from feeling alone or unsure about your next step
It does not establish a validated human dose, half-life, or dosing schedule for either compound
You need both to ensure a complete and functional recovery